menu search

RMD / ResMed (RMD) Q2 Earnings in Line, Revenues Miss Estimates

ResMed (RMD) Q2 Earnings in Line, Revenues Miss Estimates
ResMed's (RMD) Q2 earnings meet estimates, with robust demand for sleep and respiratory care devices driving the top line. Read More
Posted: Jan 28 2022, 12:19
Author Name: Zacks Investment Research
Views: 111526

RMD News  

ResMed (RMD) Q1 Earnings Surpass Estimates, Margins Down

By Zacks Investment Research
October 27, 2023

ResMed (RMD) Q1 Earnings Surpass Estimates, Margins Down

ResMed's (RMD) solid revenue growth in the first quarter of fiscal 2024 reflects the strength of AirSense 10 and AirSense 11 sleep devices and robust more_horizontal

ResMed Inc. (RMD) Q1 2024 Earnings Call Transcript

By Seeking Alpha
October 26, 2023

ResMed Inc. (RMD) Q1 2024 Earnings Call Transcript

ResMed Inc. (NYSE:RMD ) Q1 2024 Results Conference Call October 26, 2023 4:30 PM ET Company Participants Amy Wakeham - Chief Communications and Invest more_horizontal

ResMed (RMD) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

By Zacks Investment Research
October 26, 2023

ResMed (RMD) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for ResMed (RMD) give a sense of how its business performed in the quarter ended September 2023, it might be worth consid more_horizontal

ResMed (RMD) Gains From Strong Device Sales Amid Macro Woes

By Zacks Investment Research
October 9, 2023

ResMed (RMD) Gains From Strong Device Sales Amid Macro Woes

ResMed's (RMD) respiratory care business continues to drive growth and the adoption of bilevel and other non-invasive ventilator solutions worldwide. more_horizontal

Here's Why Investors Should Retain ResMed (RMD) Stock for Now

By Zacks Investment Research
October 3, 2023

Here's Why Investors Should Retain ResMed (RMD) Stock for Now

Investors continue to be optimistic about ResMed (RMD) due to the core business' performance and sustained growth in the SaaS business. more_horizontal

ResMed (RMD) Stock Jumps 3.8%: Will It Continue to Soar?

By Zacks Investment Research
September 28, 2023

ResMed (RMD) Stock Jumps 3.8%: Will It Continue to Soar?

ResMed (RMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the st more_horizontal

ResMed - Trading Opportunity Now

By Seeking Alpha
September 12, 2023

ResMed - Trading Opportunity Now

ResMed is the global leader in the sleep apnea market. Sales growth accelerated during COVID and again recently as a result of a product recall from i more_horizontal

3 Reasons ResMed's CEO Isn't Worried About Ozempic or Wegovy

By The Motley Fool
September 1, 2023

3 Reasons ResMed's CEO Isn't Worried About Ozempic or Wegovy

Some investors in ResMed, which makes machines for people with sleep apnea, think that effective new weight-loss drugs could shrink its addressable ma more_horizontal


Search within

Pages Search Results: